• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝病患者血清糖类抗原19-9非特异性升高与循环中黏附分子水平升高有关。

Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules.

作者信息

Fabris C, Falleti E, Pirisi M, Soardo G, Toniutto P, Vitulli D, Bortolotti N, Gonano F, Bartoli E

机构信息

Department of Experimental and Clinical Pathology and Medicine, University of Udine, Italy.

出版信息

Clin Chim Acta. 1995 Dec 15;243(1):25-33. doi: 10.1016/0009-8981(95)06150-9.

DOI:10.1016/0009-8981(95)06150-9
PMID:8747511
Abstract

Sialyl-Lewisa antigen (SLe(a)), the immune determinant of carbohydrate antigen 19-9 (CA 19-9), is the ligand of E-selectin. To verify the possibility of an association between nonspecific elevation of CA 19-9 and adhesion molecules, sera from 12 patients with acute hepatitis, 55 with non-cirrhotic chronic liver disease, 33 with cirrhosis and 25 with hepatocellular carcinoma, were tested for common liver function tests. Besides, CA 19-9 and soluble forms of E-selectin, VCAM-1 and ICAM-1 were measured immunoenzymatically. One-way analysis of variance demonstrated that mean CA 19-9 concentration differed among groups (F 15.27, P < 0.0001) with the highest values found in patients with acute hepatitis. By univariate analysis, the strongest correlation of CA 19-9 was with soluble ICAM-1, which by stepwise multiple regression analysis was the only independent predictor of elevated CA 19-9 (multiple R 0.560). The association between ICAM-1 and CA 19-9 might originate in the biliary cells where they might be simultaneously overexpressed during inflammatory processes.

摘要

唾液酸化路易斯抗原a(SLe(a))是糖类抗原19-9(CA 19-9)的免疫决定簇,也是E-选择素的配体。为了验证CA 19-9非特异性升高与黏附分子之间关联的可能性,我们检测了12例急性肝炎患者、55例非肝硬化慢性肝病患者、33例肝硬化患者和25例肝细胞癌患者血清的常规肝功能指标。此外,采用免疫酶法检测了CA 19-9以及E-选择素、血管细胞黏附分子1(VCAM-1)和细胞间黏附分子1(ICAM-1)的可溶性形式。单因素方差分析表明,各组间CA 19-9的平均浓度存在差异(F = 15.27,P < 0.0001),急性肝炎患者中的CA 19-9浓度最高。单变量分析显示,CA 19-9与可溶性ICAM-1的相关性最强,逐步多元回归分析表明,可溶性ICAM-1是CA 19-9升高的唯一独立预测因子(复相关系数R = 0.560)。ICAM-1与CA 19-9之间的关联可能源于胆管细胞,在炎症过程中它们可能同时过度表达。

相似文献

1
Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules.肝病患者血清糖类抗原19-9非特异性升高与循环中黏附分子水平升高有关。
Clin Chim Acta. 1995 Dec 15;243(1):25-33. doi: 10.1016/0009-8981(95)06150-9.
2
Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.慢性肝炎、肝硬化和肝细胞癌患者血清E-选择素浓度。
J Cancer Res Clin Oncol. 2000 Jun;126(6):345-51. doi: 10.1007/s004320050354.
3
Circulating standard CD44 isoform in patients with liver disease: relationship with other soluble adhesion molecules and evaluation of diagnostic usefulness.肝病患者循环中的标准CD44异构体:与其他可溶性黏附分子的关系及诊断效用评估
Clin Biochem. 1997 Feb;30(1):69-73. doi: 10.1016/s0009-9120(96)00135-x.
4
Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis.急性和慢性肝病患者血清中细胞间黏附分子-1浓度:与疾病活动度及肝硬化的关系
Hepatology. 1993 Oct;18(4):798-802. doi: 10.1002/hep.1840180408.
5
Evaluation of CA 125 as a serum marker of hepatocellular carcinoma.评估CA 125作为肝细胞癌血清标志物的作用。
Int J Cancer. 1990 Nov 15;46(5):805-7. doi: 10.1002/ijc.2910460510.
6
Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis.胆汁淤积是肝硬化患者CA 19-9水平异常的主要决定因素。
Int J Biol Markers. 2000 Jul-Sep;15(3):226-30. doi: 10.1177/172460080001500304.
7
[Soluble cell adhesion molecules in chronic renal graft rejection].[慢性肾移植排斥反应中的可溶性细胞黏附分子]
Pol Arch Med Wewn. 1998 Nov;100(5):410-8.
8
Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes.自身免疫性肝病中循环细胞间黏附分子-1(ICAM-1)以及细胞因子刺激的人肝细胞产生ICAM-1的证据。
Clin Exp Immunol. 1994 Jan;95(1):83-90. doi: 10.1111/j.1365-2249.1994.tb06019.x.
9
Intercellular adhesion molecule-1 release from human hepatocellular carcinoma.人肝细胞癌中细胞间黏附分子-1的释放
Cancer Detect Prev. 1996;20(4):308-15.
10
Serum soluble vascular-cell adhesion molecule-1 (VCAM-1) in patients with acute and chronic liver diseases.急慢性肝病患者血清可溶性血管细胞黏附分子-1(VCAM-1)
Dis Markers. 1996 Aug;13(1):11-7. doi: 10.1155/1996/129325.

引用本文的文献

1
Effects of Tofacitinib Therapy on Circulating Tumour-Associated Antigens and Their Relationship with Clinical, Laboratory and Vascular Parameters in Rheumatoid Arthritis.托法替布治疗对类风湿关节炎患者循环肿瘤相关抗原的影响及其与临床、实验室和血管参数的关系
Biomolecules. 2025 Apr 30;15(5):648. doi: 10.3390/biom15050648.
2
Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.术前癌抗原 19-9:在甲胎蛋白阴性肝细胞癌患者中的被忽视作用。
J Gastrointest Surg. 2017 Dec;21(12):2025-2032. doi: 10.1007/s11605-017-3528-5. Epub 2017 Aug 24.
3
Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.
血清 CD44、细胞间黏附分子-1 和血管细胞黏附分子-1 水平对惰性非霍奇金淋巴瘤患者的预后价值。
Leuk Lymphoma. 2012 Jan;53(1):50-6. doi: 10.3109/10428194.2011.616611. Epub 2011 Oct 24.